Animalcare Group plc (ANCR.L)
ValueMarkers Composite Index
63% below intrinsic value ($8)
Animalcare Group plc (ANCR.L) — VMCI valuation read
ANCR.L screens at VMCI 55/100, a 5-point gap above the Healthcare sector median (50). For a mid-cap Animalcare Group plc share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.
ANCR.L has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.
**Investor frame.** Value: ANCR.L trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.3x leaves covenant headroom, which sets the rate-cycle exposure for Animalcare Group plc.
ANCR.L rose 2.5% over the trailing 7 days, with a -22.8% read on a 30-day basis.
Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc was incorporated in 1972 and is based in York, the United Kingdom.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.